Aramark director granted 5,124 deferred stock units

Aramark director Kevin Wills reported a new equity grant.

Accepted by SEC EDGAR 02/04/2026 - 04:34 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Aramark director Kevin Wills reported a new equity grant. On 02/03/2026, he received 5,124 deferred stock units at a reference price of $38.06 per share, increasing his beneficial ownership to 21,855.732 shares of common stock held directly.

The deferred stock units will vest on the day before the first annual stockholders' meeting of Aramark that occurs after the grant date, subject to his continued board service. If vested, they will be settled in shares of common stock on the first day of the seventh month after his departure from the board.

Insider Trade Summary

Grant/Award: 5,124 shares

Grant/Award 1 txn

Insider Wills Kevin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,124	$38.06	$195K

Holdings After Transaction: Common Stock — 21,855.732 shares (Direct)

Holdings Before and After: Common Stock, 16,731.732 to 21,855.732 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) director Kevin Wills report?

Aramark director Kevin Wills reported receiving 5,124 deferred stock units on 02/03/2026 at a reference price of $38.06 per share. This equity grant increased his directly held beneficial ownership to 21,855.732 shares of Aramark common stock, according to the Form 4 filing.

How many Aramark (ARMK) shares does Kevin Wills beneficially own after this grant?

Following the grant, Kevin Wills beneficially owns 21,855.732 shares of Aramark common stock directly. This total reflects the addition of 5,124 deferred stock units reported in the Form 4, which are tied to Aramark common stock as the underlying security.

What are the vesting terms of Kevin Wills’ deferred stock units at Aramark (ARMK)?

The 5,124 deferred stock units vest on the day before the first Aramark annual stockholders' meeting occurring after the grant date, subject to his continued service as a director. This means vesting depends on him remaining on the board through that specified meeting date.

When will Kevin Wills’ Aramark deferred stock units be settled into common shares?

If the deferred stock units vest, they will be settled in Aramark common stock on the first day of the seventh month after Kevin Wills departs from the board. Settlement therefore occurs well after his board service ends, based on this fixed post-departure schedule.

Is Kevin Wills’ Aramark (ARMK) transaction a purchase or an award of stock?

The Form 4 transaction is coded “A” and described as a grant of 5,124 deferred stock units, not an open-market purchase or sale. These units represent equity-based director compensation that converts into Aramark common stock upon vesting and later settlement.

What type of security underlies Kevin Wills’ deferred stock units at Aramark (ARMK)?

The deferred stock units are tied to Aramark common stock as the underlying security. Once the units vest and are settled, they will be delivered in shares of Aramark common stock rather than cash, aligning the director’s compensation with shareholder equity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wills Kevin

(Last) (First) (Middle)

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		A		5,124(1)	A	$38.06	21,855.732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.